Systemic consequences of ventricular assist devices: Alterations of coagulation, immune function, inflammation, and the neuroendocrine system

Artificial Organs

Volumn 26, Issue 11, 2002, Pages 902-908

  Hampton, Craig R ^a   Verrier, Edward D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Assist device; Coagulation; Inflammation Infection; Ventricular assist device

Indexed keywords

FIBER OPTIC SENSORS; PATHOLOGY;

'CURRENT; ASSIST DEVICE; BLEEDINGS; DESTINATION THERAPY; HEART FAILURE; IMMUNE FUNCTION; INFLAMMATION-INFECTION; NEUROENDOCRINE SYSTEMS; SYSTEMIC INFLAMMATION; VENTRICULAR ASSIST DEVICE;

COAGULATION;

ADRENALIN; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; FAS ANTIGEN; FIBRIN DEGRADATION PRODUCT; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NORADRENALIN; PREKALLIKREIN; T LYMPHOCYTE RECEPTOR; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DEVICE INFECTION; FIBRINOLYSIS; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; IMMUNOMODULATION; INFECTION RISK; INFLAMMATION; LYMPHOCYTE FUNCTION; NEUROENDOCRINOLOGY; PLASMA RENIN ACTIVITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOPERATION; T LYMPHOCYTE; THROMBOEMBOLISM;

EID: 0036429956     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.07122.x     Document Type: Article

References (32)

1. American Heart Association (AHA). 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001. Available at: http:www.americanheart.org/presenter.jhtml?identifier=728.
2. Goldstein D J, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
3. United Network for Organ Sharing (UNOS). Critical Data: US Facts About Transplantation. 2001. Available at: http://www.unos.org/Frame_default.asp?Category=Newsdata.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
5. Stevenson LW, Kormos RL. Mechanical cardiac support 2000: Current applications and future trial design. J Am Coll Cardiol 2001;37:340-70.
6. Frazier OH. Mechanical cardiac assistance: Historical perspectives. Semin Thorac Cardiovasc Surg 2000;12:207-19.
7. Kasirajan V, McCarthy PM, Hoercher KJ, Starling RC, Young JB, Banbury MK, Smedira NG. Clinical experience with long-term use of implantable left ventricular assist devices: Indications, implantation, and outcomes. Semin Thorac Cardiovasc Surg 2000;12:229-37.
8. Moazami N, Roberts K, Argenziano M, Catanese K, Mohr JP, Rose EA, Oz MC. Asymptomatic microembolism in patients with long-term ventricular assist support. ASAIO J 1997;43:177-80.
9. Portner PM, Jansen PGM, Oyer PE, Wheeldon DR, Ramasamy N. Improved outcomes with an implantable left ventricular assist system: A multicenter study. Ann Thorac Surg 2001;71:205-9.
10. Himmelreich G, Ullmann H, Riess H, Rosch R, Loebe M, Schiessler A, Hetzer R. Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. ASAIO J 1995;41:M790-4.
11. Wang IW, Kottke-Marchant K, Vargo RL, McCarthy PM. Hemostatic profiles of HeartMate ventricular assist device recipients. ASAIO J 1995;41:M782-7.
12. Livingston ER, Fisher CA, Bibidakis EJ, Pathak AS, Todd BA, Furukawa S, Mcclurken JB, Addonizio VP, Jeevanandam V. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 1996;94(9 Suppl S):227-34.
13. Spanier T, Oz M, Levin H, Weinberg A, Stamatis K, Stern D, Rose E, Schmidt AM. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996;112:1090-7.
14. Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg 1999;118:404-13.
15. Grossi P, Dalla Gasperina D, Pagani F, Marone P, Vigano M, Minoli L. Infectious complications in patients with the Novacor left ventricular assist system. Transplant Proc 2001;33:1969-71.
16. Mehta SM, Aufiero TX, Pae WE, Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation - Sixth official report - 1994. J Heart Lung Transplant 1995;14:585-93.
17. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 1999;354:550-5.
18. Itescu S, Ankersmit JH, Kocher AA, Schuster MD. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis 2000;43:67-80.
19. Rothenburger M, Wilhelm M, Hammel D, Schmid C, Plenz G, Tjan TDT, Baba H, Schluter B, Scheld HH, Deng MC, Erren M. Immune response in the early postoperative period after implantation of a left-ventricular assist device system. Transplant Proc 2001;33:1955-7.
20. Erren M, Schluter B, Fobker M, Plenz G, Baba H, Willeke P, Kwiotek R, Junker R, Assmann G, Scheld HH, Deng MC. Immunologic effects of implantation of left ventricular assist devices. Transplant Proc 2001;33:1965-8.
21. Niebauer J. Inflammatory mediators in heart failure. Int J Cardiol 2000;72:209-13.
22. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66(5 Suppl):S12-6; discussion S25-8.
23. Hummel M, Czerlinski S, Friedel N, Liebenthal C, Hasper D, Vonbaehr R, Hetzer R, Volk HD. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Crit Care Med 1994;22:448-54.
24. Goldstein D J, Moazami N, Seldomridge JA, Laio H, Ashton RC, Naka Y, Pinsky D J, Oz MC. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997;63:971-4.
25. Torre-Amione G, Stetson S J, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation 1999;100:1189-93.
26. Birks EJ, Latif N, Owen V, Bowles C, Felkin LE, Mullen AJ, Khaghani A, Barton PJR, Polak JM, Pepper JR, Banner NR, Yacoub MH. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation 2001:104(12 Suppl S):I233-40.
27. Corry DC, Delucia A, Zhu H, Radcliffe RR, Brevetti GR, Elkhatib H, Vance S J, Moyer BR, Cotts WG, Richenbacher WE. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J 1998;44:M347-51.
28. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995;92(9 Suppl S):191-5.
29. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouadtarazi FM. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996;93:1515-19.
30. Delgado R 3rd, Radovancevic B, Massin EK, Frazier OH, Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J 1998;44:299-302.
31. Noirhomme P, Jacquet L, Underwood M, E1 Khoury G, Goenen M, Dion R. The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure. Eur J Cardiothorac Surg 1999;16:63-7.
32. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, Kirklin JK, Bourge RC. Cardiac transplant outcome of patients supported on left ventricular assist device versus intravenous inotropic therapy. J Heart Lung Transplant 2001; 20:449-56.